European Innovation
100,000欧元的赠款资金
优胜者
AlphaBiomics develops microbiome-based precision medicine solutions to predict drug response and improve drug therapy. By deciphering how gut microbiome influences individual responses to medicines, AlphaBiomics predicts how well individuals will respond to particular therapies and designs companion therapeutics to boost patient response to their medicines. AlphaBiomics will employ their platform to deliver safer and more efficacious immunotherapy in autoimmune diseases.
The Challenge
欧洲制药市场预计将从2015年的1690亿欧元增长到2022年的2060亿欧元。资源）。20世纪最具创新性的制药研究人员之一Paul Janssen博士首先在欧洲建立了Janssen Pharmaceutica N.V.六十多年前，为发现和开发80多种新药物奠定了基础。仅比利时生物技术行业就为2016年的研究和发展汇入了34亿欧元，比10年前的惊人增长了123％。
为了庆祝并与这些在人类医疗保健中的这些进步，约翰逊和约翰逊创新有限公司以及约翰逊和约翰逊创新的合作，JLABS发起了欧洲创新Quickfire挑战赛。具有最佳想法，技术或解决方案的创新者可以改善人类医疗保健并影响欧洲生态系统的赠款最多可获得100,000欧元的赠款，以及在可用JLABS的居留权中获得一年居留权的凭证并进入全球JLABS社区。
jlabsis continuing to expand towards a truly global open innovation ecosystem by nurturing breakthrough science at a growing network of JLABS locations, including upcoming launches spanning from New York City to Shanghai. This unique model provides entrepreneurs with access to state-of-the-art infrastructure, expertise, and funding opportunities in a no-strings-attached environment.
Rewards and benefits
- 1 year residency at an available JLABS locations
- 访问全局JLABS网络
兴趣范围
我们鼓励从事人类医疗方面各个方面的公司的申请，并在以下领域特别感兴趣：
- 药品
- Consumer products
- Medical devices
- Global public health
- Health technologies
- 跨部门倡议
Why this challenge matters to us:
在Johnson＆Johnson Innovation，我们认为一个好主意可以来自任何地方，我们的目标是找到新的创新技术，为世界各地的患者提供解决方案。共同努力，我们可以激发下一个将改变健康轨迹的好主意。
经常问的问题
确保您的浏览器是最新的，并接受cookie。您可以通过https://jnjawards.fluidreview.com/helpdesk/contact/if you are having technical difficulties as well.
For challenges involving residency at JLABS, that entails 1 lab bench and 1 workstation (desk) for 2 people maximum. If you have more employees, we can rent out an additional residency.
每个申请人将被要求提交背景调查，这要获得最低费用。我们还收集了在租赁期末可退还的存款。可能还有其他费用，但这将取决于公司在JLABS中所做的工作。EH＆S废物，专业设备，印刷和电话也可能有费用。
No, any additional fees and paperwork are up to the winner.
您将有机会，并鼓励您上传支持材料，例如幻灯片，研究论文和视频，作为您应用程序的一部分。您可以提交视频以及打字的响应。最大长度为2分钟。
不要提交机密信息。仅应提交非固定信息，并且您提交的任何内容都将被视为非机密。
由于这是一个没有连接的字符串的安排，因此JLABS不会获得任何IP。任何IP创建和/或保护仍然是发明者的唯一责任。
不，不需要专利申请。但是，您不应提交任何要保密的信息，也不应对发明的未来专利性产生负面影响。
We encourage all to apply. Find out more about what areas we desire to explore here:https://www.jnjinnovation.com/partnering
Each Challenge has its own terms & conditions that can be found prior to filling out the application.
解决方案将由审阅者和法官小组评估其满足以下标准的能力：
- Potential impact
- 解决方案的独特性和当前市场的竞争水平
- Quality & feasibility of technology
- 团队信誉和能力
- 利用JLABS居住的计划
- 想法提交概述了对欧洲创新生态系统的兴趣
请联系[email protected]with any questions.
You can setup an account athttp：// jnjawards.fluidreview.com。You are able to save your work and log back in to finish at a later time if needed.
申请流程:
解决方案将由审阅者和法官小组评估其满足以下标准的能力：
- Potential impact
- 解决方案的独特性和当前市场的竞争水平
- Quality & feasibility of technology
- 团队信誉和能力
- 利用JLABS居住的计划
- 想法提交概述了对欧洲创新生态系统的兴趣
时间线
关于Johnson＆Johnson Innovation，Jlabs
强生公司创新,JLABS (JLABS)是一个global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors.
JLABS目前在世界各地的创新热点地区都有地点，并制作了企业家计划和运动，以寻求最好的科学，例如全球的Quickfire挑战。乐动体育为什么赞助西甲JLABS旗舰店于2012年在圣地亚哥的Janssen西海岸研究中心开业，从那时起，在旧金山建立了两个地点 - 一个通过与加利福尼亚州定量生物科学研究所（QB3）合作，在South San san San San San San San San San San San San San San San Sandity建立了两个地点。弗朗西斯科。JLABS还通过与德克萨斯州医疗中心（TMC）的合作，通过与安大略省政府和多伦多大学的多伦多合作，通过与休斯敦的UMass合作，通过与UMASS合作在马萨诸塞州洛厄尔的Labcentral合作，位于波士顿。。。有关JLABS的更多信息，请访问www.www.2574design.com。
About Johnson & Johnson Innovation
Johnson & Johnson Innovation Limited focuses on accelerating early-stage innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation – JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information, visitwww.jnjinnovation.com或关注@jnjinnovation